Longitudinal cell-free DNA characterization by low-coverage whole-genome sequencing in patients undergoing high-dose radiotherapy

Overview of attention for article published in Radiotherapy & Oncology, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 5,050)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 33,134 followers.

RT @Mat_Guc: Liquid biopsy using low-coverage whole-genome sequencing for early response assessment in radiation oncology https://t.co/1Fm…

RT @Mat_Guc: Liquid biopsy using low-coverage whole-genome sequencing for early response assessment in radiation oncology https://t.co/1Fm…

RT @Mat_Guc: Liquid biopsy using low-coverage whole-genome sequencing for early response assessment in radiation oncology https://t.co/1Fm…

RT @Mat_Guc: Liquid biopsy using low-coverage whole-genome sequencing for early response assessment in radiation oncology https://t.co/1Fm…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.